{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:19:09Z","timestamp":1789100349923,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ijcard.2020.01.021","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T11:02:32Z","timestamp":1578740552000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team"],"prefix":"10.1016","volume":"304","author":[{"given":"Francesco","family":"Pelliccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ferrazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Gragnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Rapezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Seggewiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi H.","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.01.021_bb0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jacc.2008.11.069","article-title":"The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy","volume":"54","author":"Maron","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.20.1.1","article-title":"Asymmetrical hypertrophy of the heart in young adults","volume":"20","author":"Teare","year":"1958","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0025","unstructured":"B. J. Gersh, B.J. Maron, R.O. Bonow, et al. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 58 (2011) e212\u2013e260."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0030","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0035","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.29.3.422","article-title":"The circulatory response of patients with idiopathic hypertrophic subaortic stenosis: to nitroglycerin and to the Valsalva maneuver","volume":"29","author":"Braunwald","year":"1964","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.CIR.26.3.325","article-title":"Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis","volume":"26","author":"Wigle","year":"1962","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0045","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijcard.2017.04.039","article-title":"Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy","volume":"243","author":"Lu","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.hrtlng.2003.07.004","article-title":"Systolic anterior motion of the anterior mitral valve leaflet post-surgical mitral valve repair","volume":"32","author":"Charls","year":"2003","journal-title":"Heart. Lung."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0060","doi-asserted-by":"crossref","unstructured":"F. Pelliccia, V. Pasceri, G. Limongelli, et al. Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis. Int. J. Cardiol. 243 (2017) 379\u2013384.","DOI":"10.1016\/j.ijcard.2017.06.071"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0065","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ejhf.541","article-title":"Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives","volume":"18","author":"Ammirati","year":"2016","journal-title":"Eur. J. Heart. Fail."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0070","doi-asserted-by":"crossref","first-page":"H1720","DOI":"10.1152\/ajpheart.00339.2015","article-title":"N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy","volume":"309","author":"Wilder","year":"2015","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0075","doi-asserted-by":"crossref","unstructured":"Axelsson, K. Iversen, N. Vejlstrup, et al. Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial. Lancet. Diabetes, Endocrinol. 3 (2015) 123\u2013131.","DOI":"10.1016\/S2213-8587(14)70241-4"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0080","doi-asserted-by":"crossref","unstructured":"Olivotto, J.L. Hellawell, R. Farzaneh-Far, et al. Novel approach targeting the complex pathophysiology of hypertrophic cardiomyopathy: the impact of late sodium current inhibition on exercise capacity in subjects with symptomatic hypertrophic cardiomyopathy (LIBERTY-HCM) Trial. Circ. Heart. Fail. 9 (2016) e002764.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002764"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0085","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ahj.2012.03.018","article-title":"A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention","volume":"163","author":"Pelliccia","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/M18-3016","article-title":"Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial","volume":"170","author":"Heitner","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0095","doi-asserted-by":"crossref","unstructured":"Olivotto, C. Ho, D. Jacoby, et al. EXPLORER-HCM: phase 3 randomized, multi-center, double-blind, placebo-controlled study to evaluate mavacamten (MYK-461) in adults with symptomatic obstructive hypertrophic cardiomyopathy. Circulation. 138 (2018) A16466.","DOI":"10.1161\/circ.138.suppl_1.17067"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0100","doi-asserted-by":"crossref","unstructured":"L.A. Robertson, D.R. Armas, E. Robbie, et al. A first in human study of the selective cardiac myosin inhibitor, CK-3773274. J. Cardiac. Fail. 25 (2019) S79-S80.","DOI":"10.1016\/j.cardfail.2019.07.225"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.CIR.29.5S4.IV-120","article-title":"Idiopathic hypertrophic subaortic stenosis: II. Operative treatment and the results of pre- and postoperative hemodynamic evaluations","volume":"29","author":"Morrow","year":"1964","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0110","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.amjcard.2019.01.041","article-title":"Role of preoperative cardiovascular magnetic resonance in planning ventricular septal myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"123","author":"Spirito","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11748-017-0815-8","article-title":"Application of cryoenergy to improve septal exposure during transaortic septal myectomy in hypertrophic obstructive cardiomyopathy","volume":"66","author":"Pozzoli","year":"2018","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.21037\/acs.2017.06.04","article-title":"Current state of the art and future of myectomy","volume":"6","author":"Yacoub","year":"2017","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0125","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jacc.2015.07.069","article-title":"Transaortic chordal cutting: mitral valve repair for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy","volume":"66","author":"Ferrazzi","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2019.09.029","article-title":"Efficacy of combined Cox Maze IV and ventricular septal myectomy for treatment of atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy","volume":"125","author":"Boll","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0135","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1161\/01.CIR.98.22.2415","article-title":"Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography","volume":"98","author":"Faber","year":"1998","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4244\/EIJ-D-18-00959","article-title":"Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisal","volume":"15","author":"Pelliccia","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0145","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jacc.2007.05.018","article-title":"Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial","volume":"50","author":"Olivotto","year":"2007","journal-title":"J. Am. Coll.Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0150","doi-asserted-by":"crossref","unstructured":"M. Liebregts. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. JACC.Heart. Failure. 3 (2015) 896\u2013905.","DOI":"10.1016\/j.jchf.2015.06.011"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0155","first-page":"107","article-title":"A meta-analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy","volume":"88","author":"Singh","year":"2016","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0160","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.jacc.2018.09.064","article-title":"Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy","volume":"72","author":"Batzner","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0165","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCGENETICS.108.821314","article-title":"Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy","volume":"2","author":"Kaski","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0170","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/heartjnl-2011-300531","article-title":"Hypertrophic cardiomyopathy in children","volume":"98","author":"Moak","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0175","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/eurheartj\/ehy798","article-title":"Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom","volume":"40","author":"Norrish","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2017.07.068","article-title":"Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results","volume":"245","author":"Calcagni","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0185","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00246-014-1058-4","article-title":"Semi-supine exercise stress echocardiography in children and adolescents: feasibility and safety","volume":"36","author":"Ciliberti","year":"2015","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0190","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.athoracsur.2005.03.109","article-title":"Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: early and late results","volume":"80","author":"Minakata","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0195","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1017\/S1047951117002384","article-title":"Disopyramide use in infants and children with hypertrophic cardiomyopathy","volume":"28","author":"O'Connor","year":"2018","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hrthm.2011.09.004","article-title":"Cardiac rhythm devices in the pediatric population: utilization and complications","volume":"9","author":"Czosek","year":"2012","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0205","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.jacc.2011.09.020","article-title":"Percutaneous radiofrequency septal reduction for hypertrophic obstructive cardiomyopathy in children","volume":"58","author":"Sreeram","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0210","doi-asserted-by":"crossref","unstructured":"G. Norrish, N. Cantarutti, E. Pissaridou, et al. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: a systematic review and meta-analysis. Eur. J. Prev. Cardiol. 24 (2017) 1220\u20131230.","DOI":"10.1177\/2047487317702519"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0215","doi-asserted-by":"crossref","unstructured":"S. Balaji, M.P. DiLorenzo, F.A. Fish, et al. Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: an international multicenter study. Heart. Rhythm. 16 (2019) 1462\u20131467.","DOI":"10.1016\/j.hrthm.2019.04.040"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0220","doi-asserted-by":"crossref","unstructured":"G. Norrish, T. Ding, E. Field, et al. Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids). JAMA. Cardiol. 2019 Aug 14. doi: https:\/\/doi.org\/10.1001\/jamacardio.2019.2861.","DOI":"10.1093\/eurheartj\/ehz747.0062"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jacc.2017.02.080","article-title":"Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a word of endorsement","volume":"70","author":"Liebregts","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0230","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.jtcvs.2017.08.083","article-title":"It is the time for a heart team approach for patients with hypertrophic cardiomyopathy","volume":"154","author":"Ad","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamacardio.2016.0277","article-title":"Hypertrophic cardiomyopathy-one case per year?: a clarion call to do what is right","volume":"1","author":"Ommen","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003-2011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA. Cardiol."},{"key":"10.1016\/j.ijcard.2020.01.021_bb0245","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/CIRCULATIONAHA.110.950089","article-title":"Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute","volume":"122","author":"Force","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.01.021_bb0250","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2018.10.091","article-title":"Sex-related differences in cardiomyopathies","volume":"286","author":"Pelliccia","year":"2019","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320300954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320300954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:47:27Z","timestamp":1759092447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320300954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":50,"alternative-id":["S0167527320300954"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.01.021","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}